Osteonecrosis of the jaw related to everolimus: a case report

Dong Wook Kim1, Young-Soo Jung, Hyung-Sik Park

  • 1Department of Oral & Maxillofacial Surgery, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Republic of Korea.

Insights

Osteonecrosis of the jaw (ONJ) can cause significant patient morbidity. This case suggests that the drug everolimus, an antiangiogenic agent, may contribute to ONJ, potentially due to additive effects with other medications.

Area of Science:

  • Oncology
  • Pharmacology
  • Oral Surgery

Background:

  • Antiresorptive agents are known to cause osteonecrosis of the jaw (ONJ).
  • Antiangiogenic agents, such as everolimus, are increasingly used for managing malignant metastases.
  • Everolimus inhibits mammalian target of rapamycin (mTOR), affecting cell growth, angiogenesis, and survival.

Observation:

  • A patient developed osteonecrosis of the jaw.

Findings:

  • This case is the first to suggest a potential link between everolimus and ONJ.
  • The osteonecrosis may result from the additive effect of everolimus, possibly in combination with other therapies.

Implications:

  • Clinicians should be aware of the potential risk of ONJ when prescribing everolimus, especially in patients receiving antiresorptive agents.
  • Further research is needed to elucidate the exact mechanism and incidence of everolimus-induced ONJ.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.